BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Lorenzo R, Ferri P, Cameli M, Rovesti S, Piemonte C. Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting. Neuropsychiatr Dis Treat 2019;15:183-98. [PMID: 30662264 DOI: 10.2147/NDT.S189245] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Martins PS, Caldas F, Oliveira C, Mota J, Gonçalves M. A 10-year mirror-image study of effectiveness and cost of long-acting paliperidone palmitate injectable in patients with schizophrenia or schizoaffective disorder. Psychiatry Research 2022;312:114581. [DOI: 10.1016/j.psychres.2022.114581] [Reference Citation Analysis]
2 Bartoli F, Cavaleri D, Callovini T, Riboldi I, Crocamo C, D'agostino A, Martinotti G, Bertolini F, Ostuzzi G, Barbui C, Carrà G. Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study. Psychiatry Research 2022;309:114405. [DOI: 10.1016/j.psychres.2022.114405] [Reference Citation Analysis]
3 Cottura N, Howarth A, Rajoli RKR, Siccardi M. The Current Landscape of Novel Formulations and the Role of Mathematical Modeling in Their Development. J Clin Pharmacol 2020;60 Suppl 1:S77-97. [PMID: 33205431 DOI: 10.1002/jcph.1715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Mason K, Barnett J, Pappa S. Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate. Ther Adv Psychopharmacol 2021;11:20451253211029490. [PMID: 34349980 DOI: 10.1177/20451253211029490] [Reference Citation Analysis]
5 Olivares JM, González-Pinto A, Páramo M; PROSIGO Study Group. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. Eur Psychiatry 2021;64:e40. [PMID: 33840396 DOI: 10.1192/j.eurpsy.2021.23] [Reference Citation Analysis]
6 Pae CU, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS. Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not? Clin Psychopharmacol Neurosci 2021;19:434-48. [PMID: 34294613 DOI: 10.9758/cpn.2021.19.3.434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Peitl V, Štefanović M, Orlović I, Culej J, Rendulić A, Matešić K, Karlović D. Long acting aripiprazole influences cognitive functions in recent onset schizophrenia. Psychopharmacology (Berl) 2021;238:1563-73. [PMID: 33580813 DOI: 10.1007/s00213-021-05788-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 de Vita VM, Zapparoli HR, Reimer AE, Brandão ML, de Oliveira AR. Dopamine D2 receptors in the expression and extinction of contextual and cued conditioned fear in rats. Exp Brain Res 2021;239:1963-74. [PMID: 33885919 DOI: 10.1007/s00221-021-06116-6] [Reference Citation Analysis]
9 Olivares JM, Fagiolini A. Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly. Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice: A Pooled Analysis. Front Psychiatry 2022;13:877867. [DOI: 10.3389/fpsyt.2022.877867] [Reference Citation Analysis]
10 Her YN, Chen CY, Chang HA, Kao YC, Wan FJ, Tzeng NS. Aripiprazole Long-Acting Injections Improved Control of Parkinson's Disease. Am J Ther 2022;29:e379-80. [PMID: 33021527 DOI: 10.1097/MJT.0000000000001269] [Reference Citation Analysis]
11 Latorre V, Papazacharias A, Lorusso M, Nappi G, Clemente P, Spinelli A, Carrieri G, D'Ambrosio E, Gattullo M, Uva AE, Semisa D. Improving the "real life" management of schizophrenia spectrum disorders by LAI antipsychotics: A one-year mirror-image retrospective study in community mental health services. PLoS One 2020;15:e0230051. [PMID: 32155207 DOI: 10.1371/journal.pone.0230051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Moretti V, Brunetti C, Candaten A, Cannavò D, Manfredi M, Maserati M, Piccinini A, Rinaldi M, Artioli G, Sarli L, Ferri P. Take a picture! The role of visual methods in understanding psychiatric patient's everyday life. Acta Biomed 2021;92:e2021028. [PMID: 34328131 DOI: 10.23750/abm.v92iS2.11945] [Reference Citation Analysis]
13 Karlović D, Silić A, Crnković D, Peitl V. Effects of aripiprazole long-acting injectable antipsychotic on hospitalization in recent-onset schizophrenia. Hum Psychopharmacol 2021;36:e2763. [PMID: 33058260 DOI: 10.1002/hup.2763] [Reference Citation Analysis]
14 Schöttle D, Janetzky W, Luedecke D, Beck E, Correll CU, Wiedemann K. The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index. BMC Psychiatry 2020;20:77. [PMID: 32087718 DOI: 10.1186/s12888-020-02488-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Di Lorenzo R, Iorio A, Pinelli M, Magarini FM, Marchi M, Sacchetti A, Calogero C, Galeazzi G, Ferri P, Rovesti S, Minarini A. Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs. NDT 2022;Volume 18:829-46. [DOI: 10.2147/ndt.s356341] [Reference Citation Analysis]